Ομοιοπαθητική Θεσσαλονίκη | omoiotherapeia.gr
Ομοιοπαθητική Θεσσαλονίκη | omoiotherapeia.gr
Ομοιοπαθητική Θεσσαλονίκη | omoiotherapeia.gr
Ομοιοπαθητική Θεσσαλονίκη | omoiotherapeia.grr
Ομοιοπαθητική Θεσσαλονίκη | omoiotherapeia.gr
Ομοιοπαθητική Θεσσαλονίκη | omoiotherapeia.gr
Ομοιοπαθητική Θεσσαλονίκη | omoiotherapeia.gr

MY HOMEOPATHIC TREATMENT

The first major feature of my Homeopathic Treatment is the Indivualization for Treatment Determination.This means that different people may have different pathogenic reasons,symptoms and syndromes even though the disease name is the same, so treatment strategies and formulas are different. So different treatment strategies will be used according to the different causative factors.

The other major principle is Totality for Treatment Determination.This means that in all Diseases the whole organism suffers,even if organ pathology is conventionally recognized in a certain organ or part of the body.So,treatment should be applied for both the diseased organ or part of the body and for the totality of all current sufferings all over the body.

 

Modern Homeopathy should care equally

for both the Patient and the Disease.

more

Your First Appointment

Just after the booking of the Appointment and  before the Consultation,you are provided  via email with a printed Questionnaire,which must be completed.  It asks for:

    •Basic  contact details, including address, phone and mobile numbers, email address

    •A brief description  of  your current health problems

    •A brief reference to your past medical history

Try to complete the questionnaire well in advance of your appointment and bring to me at your consultation appointment

more

MY HOMEOPATHIC CONSULTATION

The consultations take place in a comfortable, relaxed and friendly environment. The first time you come along for a consultation, I spend at least an hour talking through the specific symptoms,health conditions and/or disease(s) you have, obtaining all necessary details of your case history, including any relevant lab tests,medical records,etc that you might already have. During this time you will have a unique opportunity to talk in detail with me about these ailments.Any questions I ask will help me to get a good understanding of your physical and/or emotional problems.

 

Once Homeopathic treatment has started, follow-up appointments take place once every 4-8 weeks( usually every 6 weeks). During follow up appointments, it is assessed how you are getting on with the homeopathic remedies prescribed, the progress you have made according to homeopathic principles and any indicated extension of the homeopathic case taking is added and included. Further homeopathic medication is prescribed for you based on this evaluation.The whole process is about reviewing , re-formulating and proceeding the planned homeopathic treatment

 

more


Home /

MY HOMEOPATHIC CONSULTATION

The Evidence of Homeopathy in Medical Literature

You may easily have the Evidence that INTEGRATIVE CLINICAL HOMEOPATHY complies with  all the scientific standards of a mainstream medicine,visiting HERE the official medical data of PubMed,which is the most renown International Medical Archive of published articles in peer reviewed Medical Journals.

 

Just an example of Medical Research in the field of CLINICAL HOMEOPATHY applications on Infertility:

Complement Ther Med. 2016 Apr;25:39-44. doi: 10.1016/j.ctim.2015.12.016. Epub 2016 Jan 4.

Comparison between the additive effects of diluted (rFSH) and diluted/dynamized (FSH 6 cH) recombinant follicle-stimulating hormone on the in vitro culture of ovine preantral follicles enclosed in ovarian tissue.

Lima LF1, Rocha RM2, Alves AM2, Carvalho AA2, Chaves RN3, Lopes CA2, Báo SN4, Campello CC2, Rodrigues AP2, Figueiredo JR2.

Abstract

OBJECTIVE:

This study compared 2 types of recombinant follicle stimulating hormone (rFSH): diluted and diluted/dynamized, on in vitro development of ovine follicles.

METHODS:

In experiment 1, ovarian fragments were cultured for 1 or 7 days in α-MEM(+) in the absence or presence of different concentrations of diluted rFSH to determine the best concentration. In experiment 2, the effect of diluted and diluted/dynamized rFSH (rFSH 6 cH-ultradiluted and succussioned), alone or in combination, was studied.

RESULTS:

In experiment 1, compared to control, 50ng/mL of diluted rFSH induced higher rates of follicular survival after 7 days of culture and higher percentages of growing follicles at day 1 of culture (P<0.05). In experiment 2, compared to control, diluted/dynamized rFSH induced higher follicular diameter and survival rate after 7 days and early follicle activation at day 1 of culture (P<0.05). Compared to diluted rFSH, diluted/dynamized rFSH induced higher rates of follicle activation at day 1 of culture (P<0.05).

CONCLUSION:

In conclusion, compared to the control medium, diluted/dynamized rFSH promoted survival and early activation of follicles, while diluted rFSH promoted higher activation later in the culture. Thus, diluted/dynamized rFSH may be used as an alternative to diluted rFSH for the in vitro culture of ovine preantral follicles.

Another sample comes from  modern research on the application of Clinical Homeopathy in Cancer:

Homeopathy.2013 Oct; 102(4):274-82.

Anti-proliferative effects of homeopathic medicines on human kidney, colon and breast cancer cells.

Arora S1, Aggarwal A, Singla P, Jyoti S, Tandon S.

Abstract

OBJECTIVE:

Homeopathy is controversial, due to the claims made for very high dilutions. Although several theories are proposed to understand the mechanisms of action, none are scientifically verified. This study aimed to investigate the efficacy of the selected homeopathic medicines in specific in vitro cancer models.

METHODS:

We assessed the cytotoxic activity of selected homeopathic medicines in mother tincture (MT), and ultramolecular dilution (30C, 200C, 1M and 10M) against cell lines deriving from tumors of particular organs, Sarsaparilla (Sars) on ACHN cells (human renal adenocarcinoma), Ruta graveolens (Ruta) on COLO-205 (human colorectal carcinoma), and Phytolacca decandra (Phyto) on MCF-7 (human breast carcinoma). Sars was also tested against Madin-Darby canine kidney (MDCK) cells (a non-malignant cell line). Cytotoxicity was measured using the 3-(4, 5-dimethylthiazolyl-2)-2, 5-diphenyltetrazolium bromide (MTT) method, anti-proliferative activity by trypan blue exclusion assay, apoptosis determined by dual staining the cells with ethidium bromide (EB) and acridine orange (AO) dyes.

RESULTS:

MTs and ultra-diluted preparations of the three homeopathic medicines had highly significant effects in the respective cancer cell lines, producing cytotoxicity and a decrease in cell proliferation. The effects were greatest with the MTs, but in all cases and persisted, although to a lesser degree in the ultra-diluted molecular preparations. Sars showed no effect on MDCK cells. In the homeopathic medicine treated cultures, hallmarks of apoptosis were evident including, cell shrinkage, chromatin condensation and DNA fragmentation.

CONCLUSION:

This study provides preliminary laboratory evidence indicating the ability of homeopathic medicines as anticancer agents. Further studies of the action of these homeopathic remedies are warranted.

 

Homeopathic Research in Cancer

The modern academic and clinical medical research in the field of homeopathy is almost always based on the pathophysiological action of homeopathic ‘medicines’ on organs, tissues and  cells. Reference to research supporting  the effectiveness of Homeopathy, already published in peer-reviewed medical journals, is included and commented in this article.

A prospective observational study was conducted with cancer patients in two differently treated cohorts: one cohort with patients under complementary homeopathic treatment and one cohort with conventionally treated cancer patients. For a direct comparison, matched pairs with patients of the same tumour entity and comparable prognosis were to be formed. It was observed that improvement of quality of life as well as a decreased tendency of fatigue symptoms occurred in cancer patients under complementary homeopathic treatment.

Recent Academic Research in USA revealed that  ultra-diluted homeopathic remedies have cytotoxic effects on breast cancer cells. An in vitro study was conducted to determine if homeopathic products have any effect on breast cancer cell lines. Four ultra-diluted remedies  against two human breast adenocarcinoma cell lines and a cell line derived from immortalized normal human mammary epithelial cells were studied. The homeopathic remedies exerted preferential cytotoxic effects against the two breast cancer cell lines, causing cell cycle delay/arrest and apoptosis. These effects were accompanied by altered expression of the cell cycle regulatory proteins, which were likely responsible for the cell cycle delay/arrest as well as induction of apoptosis. These findings demonstrated cytotoxic biological activity against cancer cells  of these homeopathic products at their ultra-diluted doses.

Ethanolic extract of Phytolacca decandra (PD), used in homeopathy for the treatment of various ailments such as chronic rheumatism, regular conjunctivitis, psoriasis, and in some skin diseases was tested for its possible anticancer potential. Cytotoxicity of the drug was tested on both normal (peripheral blood mononuclear cells) and A375 skin melanoma cancer cells. DNA fragmentation, changes in cellular morphology, apoptosis and necrosis, if any, were  recorded. Reactive oxygen species (ROS) accumulation, if any, and expression study of apoptotic genes also were evaluated to pin-point the actual events of apoptosis. Results showed that PD administration caused a remarkable reduction in proliferation of A375 cells, without showing cytotoxicity on peripheral blood mononuclear cells. Generation of ROS and DNA damage, which made the cancer cells prone to apoptosis, were found to be enhanced in PD-treated cells. Overall results demonstrate the anticancer potentials of Phytolacca decandra on A375 melanoma cells.

Homeopathic treatment efficiency was studied in patients with advanced gallbladder, periampullary, and liver carcinomas. The authors present  cases of various pathologically confirmed malignancies. These patients underwent homeopathic therapy as the primary cancer treatment. In the cases studied, conventional cancer treatments could not be initiated due to the advanced stage of their disease, poor general health performance status, and their financial constraints. This report indicated the clinical efficacy of homeopathic  therapy in treating those cancer patients.

Induction of apoptosis of tumour cells by some potentiated homeopathic drugs was  studied  concerning possible mechanism of action. Earlier studies indicated that homoeopathic medicines are cytotoxic to tumour cells and reduced animal tumours. Homeopathic remedies were tested for their ability to induce apoptosis. Similarly, the effect of homoeopathic medicines on apoptosis was measured by microarray analysis. Homeopathic remedies produced morphological changes in the Dalton's lymphoma ascites tumour cells and induced DNA laddering, increased apoptotic gene p53 and decreased antiapoptotic gene Bcl2. Administration of potentiated homoeopathic drugs to tumour-bearing mice induced increased apoptosis of tumour cells. Microarray analysis of cells treated with homoeopathic drugs indicated that many enzymes related to apoptosis were increased by homoeopathic drugs. These data indicate that apoptosis is one of the mechanisms of tumour reduction by homeopathic drugs. A comparison of potentiated drugs with their mother tincture indicated that the potentiated drugs have biological activity similar to that of their mother tincture in spite of ultradilution.

A study was conducted on the use of homeopathy in pediatric oncology in Germany. Homeopathy is a frequently used complementary and alternative medicine (CAM) treatment in Germany. Results were presented comparing responses of homeopathy users (HUs) and users of other forms of CAM (NHUs) in pediatric oncology (PO) in Germany. Differences between these two groups (usage, associated demographic characteristics, previous experience with CAM) were investigated. 186 (45.2%) of the 367 CAM users were exposed to homeopathy. The treatment duration amounted to a median of 601 days for HUs and 282 days for NHUs. Parents with p (127; 76.5%) also used homeopathy for their child's cancer. Nonmedical practitioners played a considerably greater role as source of information than did treating physicians. In the majority of patients HUs received their prescriptions from nonmedical practitioners (56%; 29.4% of NHUs). HUs communicate more frequently with their physicians about the CAM-use (77.7% versus 65.2%) and recommend CAM more often than NHUs (94% versus 85.6%). Homeopathy is the most frequently used CAM treatment in PO in Germany. HUs sustain treatment and therapies considerably longer than NHUs. Most families who had used homeopathy before their child was diagnosed with cancer also used homeopathy for the treatment of their child's cancer. Compared to other CAM treatments, patient satisfaction with homeopathy appears to be very high.

A tumour therapy with Amanita phalloides  for stabilization of B-cell chronic lymphatic leukemia was studied. In tumour cells, RNA polymerase II is more active than in other somatic cells. Amanita phalloides contains amanitin, inhibiting RNA polymerase II. Partial inhibition with amanitin influences tumour cell - but not normal cell - activity. To widen the treatment spectrum, homeopathic dilutions of Amanita phalloides, containing amanitin, were given to  patients with leukemia. Monitoring the leukemic cell count, different doses of amanitin were given. This homeopathic tumour therapy showed high potential to provide a gentle and essential medical treatment.

A clinical evaluation of a complex homeopathic injection therapy in the management of pain in patients after breast cancer treatment was performed. In breast cancer patients, post-treatment pain often appearing after several months and strongly impairing health-related quality of life. Conventional methods of pain reduction are often ineffective or even harmful. Injection therapy with a  complex homeopathic  medication with analgesic properties, used for treatment of the pain associated with trauma as well as with mediators of inflammation, was proposed as an innovative approach for pain relief after breast cancer treatment. After the last injection, all patients experienced a marked reduction of their level of pain on average from 7.6 +/- 1.5 to 2.4 +/- 1.4 points on a scale from 1 to 10 points. After a follow-up observational phase of 3 and 6 months, pain score ratings increased slightly again in some patients but remained consistently low in others. In any case, the ratings of pain levels did not reach the values assessed before the start of these injections. Similarly, health-related quality of life improved with this injection therapy. The perception of pain relief with homeopathic injections was high, reflecting an overall perceived positive outcome and tolerability of this treatment. This case series represents one more encouraging approach to using this complex homeopathic injection for pain relief in breast cancer patients.

According to modern classic pathology, epithelial-stromal interactions, mediated by the extracellular matrix, play a pivotal role in normal mammary gland function. It is now recognized that a specific environment is necessary for tumorigenesis; indeed, it has been postulated that cancer can be a physiological response to an abnormal stromal environment. An abnormal stroma can be regarded as a classical promoter in the terminology of carcinogenesis, in that the dysfunction of normal epithelial-mesenchymal interactions increases the probability that the pre-neoplastic lesion will progress to malignancy. On the other hand, in the terminology of development, the environment provided by the abnormal stroma may be considered 'permissive' for tumorigenesis by leading to the selection of cells with altered survival characteristics. These views signify that an aberrant stroma predisposes tissue to cancer by increasing the frequency with which an initiated cell proceeds to neoplasia, rather than by increasing the frequency of initiation. Importantly, normal stroma can efficiently inhibit the expression of neoplastic characteristics of tumour cells.

Conversely, perturbations in the epithelial-stromal interaction may accelerate the process of carcinogenesis, especially since carcinogen exposure elicits persistent phenotypic changes in stromal cells. These non-neoplastic stromal effects induced by carcinogens can be conducive to the expression of or to the progression of pre-neoplastic phenotypes, just as carcinoma-associated fibroblasts support malignant behaviours. Together these stromal alterations are likely to be essential to the development of frank neoplastic disease. These studies emphasize that the interactions between the epithelium and the stroma evolve dynamically, and thus will require considerable study if they are to be manipulated therapeutically.

Together, these recent studies underscore that the stromal-epithelial interface is a critical mediator of oncogenic potential. The heightened awareness of the stroma as an active participant in carcinogenesis has led to ideas for intervening in breast cancer progression by manipulating the stroma. Compared with the multiple routes taken by cells to become cancers, the response of tissues to cancer is relatively predictable. Controlling the early stages of invasive cancer growth may therefore be more readily achieved indirectly via the stroma.

So, the facts are not so simple; hunting the cancer cells only does not cover the whole story, moreover when toxic substances for the whole health economy are used, so that necessarily in each one cytotoxic chemical treatment a difficult dilemma always arises for both the physician and the patient: are the gains more than losses or the reverse and in what extent? In this dilemma at least the physician has to reply objectively and honestly, as he is bound both by medical jurisprudence and the Hippocratic Oath. Of course, any nontoxic therapy targeting to kill cancer cells, as the above mentioned cytotoxic action of homeopathic products on breast cancer cells, is certainly remarkable, impressive and promising for present and future research and clinical applications. But, Pathology itself is the Discipline that dictates directions for all of us, either conventional or ‘complementary’ therapists or researchers. Modern Pathology, considering also the principles  founded by Hippocrates and Virchow, dictates us, as above, to give priority not to the cancer cell itself only, but mainly on the integrity of the diseased tissue as a whole field and as it basically expressed by the balance between stroma and cancer cells. This is the battlefield according to both modern medical literature and of modern Holistic / Homeopathic Clinical Conception and, if we want to win, we have to adhere to it.

Certainly, conventional medicine has tried to make certain steps towards this direction, including the employment of factors inhibiting angiogenesis in the stroma of malignant tumours and, of course, this is encouraging for all, such as any conventional intervention through immune mechanisms, pathways, etc. affecting possibly cancer cells growth. From our side, the holistic in the wider sense, the homeopathic in the more specific and more familiar to me sense, a long, very long basic research, bio-theoretical approaches and clinical applications  have already offered a very rich and evidenced material ,absolutely accessibly to all the medical community, despite the hard persecutions of many pioneers in the field and their followers in many countries all over the world, unfortunately certain of them included in our European family. An example of relevant holistic /homeopathic application is Homotoxicology, a Pathology-based Homeopathic approach, which was developed certain decades ago by Dr Reckeweg in Germany. Homotoxicology deals with the structural and functional stages that an organ or tissue passes successively from mild reactive disorders, such as acute inflammations and allergies to the most dangerous ones, namely the degenerative ,the autoimmune and, finally, Cancer. According to this systematic pathogenetic chain investigation, any tissue pathology, like Cancer, first starts in the stroma and then is extended in the cells, so that the most suitable strategy is to target first of all to the stroma through appropriate homeopathic remedies’ combinations.